Legacy Advisors, LLC Pfizer Inc Transaction History

Legacy Advisors, LLC

  • $918 Million
  • Q3 2024

A detailed history of Legacy Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Legacy Advisors, LLC holds 56,554 shares of PFE stock, worth $1.51 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
56,554
Previous 51,483 9.85%
Holding current value
$1.51 Million
Previous $1.44 Million 13.61%
% of portfolio
0.18%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$27.7 - $31.39 $140,466 - $159,178
5,071 Added 9.85%
56,554 $1.64 Million
Q2 2024

Jul 30, 2024
BUY
$25.26 - $29.6 $114,781 - $134,502
4,544 Added 9.68%
51,483 $1.44 Million
Q1 2024

Apr 30, 2024
SELL
$25.89 - $29.73 $1.43 Million - $1.65 Million
-55,341 Reduced 54.11%
46,939 $1.3 Million
Q4 2023

Feb 12, 2024
BUY
$26.13 - $33.94 $14,972 - $19,447
573 Added 0.56%
102,280 $2.94 Million
Q3 2023

Nov 14, 2023
BUY
$32.09 - $37.51 $371,891 - $434,703
11,589 Added 12.86%
101,707 $3.37 Million
Q2 2023

Jul 20, 2023
BUY
$36.12 - $41.79 $930,992 - $1.08 Million
25,775 Added 40.06%
90,118 $3.31 Million
Q1 2023

May 01, 2023
BUY
$39.39 - $51.28 $394,845 - $514,030
10,024 Added 18.45%
64,343 $2.63 Million
Q4 2022

Feb 01, 2023
BUY
$41.75 - $54.5 $482,880 - $630,347
11,566 Added 27.05%
54,319 $2.78 Million
Q3 2022

Nov 09, 2022
BUY
$43.76 - $53.42 $120,515 - $147,118
2,754 Added 6.89%
42,753 $1.87 Million
Q2 2022

Jul 25, 2022
BUY
$46.53 - $55.17 $396,435 - $470,048
8,520 Added 27.07%
39,999 $2.1 Million
Q1 2022

May 11, 2022
BUY
$45.75 - $56.69 $943,365 - $1.17 Million
20,620 Added 189.89%
31,479 $1.63 Million
Q4 2021

Feb 14, 2022
SELL
$41.32 - $61.25 $40,782 - $60,453
-987 Reduced 8.33%
10,859 $641,000
Q3 2021

Oct 13, 2021
BUY
$39.25 - $50.42 $107,937 - $138,655
2,750 Added 30.23%
11,846 $510,000
Q2 2021

Jul 13, 2021
BUY
$35.91 - $40.68 $2,298 - $2,603
64 Added 0.71%
9,096 $356,000
Q1 2021

Apr 12, 2021
BUY
$33.49 - $37.77 $24,280 - $27,383
725 Added 8.73%
9,032 $327,000
Q4 2020

Jan 15, 2021
SELL
$33.47 - $42.56 $25,905 - $32,941
-774 Reduced 8.52%
8,307 $306,000
Q3 2020

Oct 08, 2020
BUY
$31.75 - $37.25 $16,414 - $19,258
517 Added 6.04%
9,081 $333,000
Q2 2020

Jul 09, 2020
SELL
$30.12 - $36.54 $113,763 - $138,011
-3,777 Reduced 30.61%
8,564 $280,000
Q1 2020

Apr 15, 2020
SELL
$27.03 - $38.62 $19,029 - $27,188
-704 Reduced 5.4%
12,341 $403,000
Q4 2019

Jan 21, 2020
BUY
$32.92 - $37.36 $10,633 - $12,067
323 Added 2.54%
13,045 $511,000
Q3 2019

Oct 10, 2019
SELL
$32.49 - $42.13 $3,898 - $5,055
-120 Reduced 0.93%
12,722 $457,000
Q2 2019

Jul 15, 2019
SELL
$36.98 - $41.52 $45,559 - $51,152
-1,232 Reduced 8.75%
12,842 $556,000
Q1 2019

Apr 08, 2019
BUY
$37.5 - $41.2 $39,262 - $43,136
1,047 Added 8.04%
14,074 $598,000
Q4 2018

Jan 14, 2019
SELL
$38.47 - $43.86 $38,008 - $43,333
-988 Reduced 7.05%
13,027 $569,000
Q3 2018

Oct 18, 2018
BUY
$34.47 - $41.81 $196,927 - $238,860
5,713 Added 68.81%
14,015 $618,000
Q2 2018

Jul 19, 2018
BUY
$32.98 - $35.16 $63,453 - $67,647
1,924 Added 30.17%
8,302 $301,000
Q1 2018

Apr 17, 2018
BUY
$31.91 - $37.02 $71,893 - $83,406
2,253 Added 54.62%
6,378 $232,000
Q4 2017

Jan 26, 2018
SELL
$33.26 - $35.29 $5,787 - $6,140
-174 Reduced 4.05%
4,125 $149,000
Q3 2017

Nov 03, 2017
SELL
$31.0 - $34.15 $18,879 - $20,797
-609 Reduced 12.41%
4,299 $153,000
Q2 2017

Nov 01, 2017
BUY
N/A
1,508 Added 44.35%
4,908 $164,000
Q4 2016

Nov 03, 2017
BUY
N/A
3,400
3,400 $110,000

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Legacy Advisors, LLC Portfolio

Follow Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email